Top Page
Tate & Lyle
(LSE:TATE)
Tate & Lyle (TATE) vs. iShares MSCI United Kingdom ETF (EWC)
Tate & Lyle Business Overview & Revenue Model
Tate & Lyle Earnings Call Summary
Tate & Lyle Financial Statement Overview
| Breakdown | |||||
| TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 1.56B | 1.65B | 1.75B | 1.38B | 1.21B | 2.88B | Gross Profit |
| 1.56B | 851.00M | 496.00M | 339.00M | 303.00M | 892.00M | EBIT |
| 187.00M | 207.00M | 226.00M | 166.00M | 157.00M | 317.00M | EBITDA |
| 329.00M | 345.00M | 300.00M | 145.00M | 209.00M | 473.00M | Net Income Common Stockholders |
| 251.00M | 188.00M | 190.00M | 236.00M | 253.00M | 245.00M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 289.00M | 437.00M | 475.00M | 110.00M | 371.00M | 271.00M | Total Assets |
| 2.77B | 2.28B | 2.51B | 3.25B | 2.97B | 2.85B | Total Debt |
| 690.00M | 590.00M | 713.00M | 679.00M | 788.00M | 722.00M | Net Debt |
| 429.00M | 153.00M | 238.00M | 569.00M | 417.00M | 451.00M | Total Liabilities |
| 1.44B | 1.04B | 1.32B | 1.63B | 1.51B | 1.45B | Stockholders Equity |
| 1.33B | 1.24B | 1.19B | 1.62B | 1.45B | 1.40B |
| Cash Flow | Free Cash Flow | ||||
| 171.00M | 98.00M | 40.00M | -11.00M | 222.00M | 259.00M | Operating Cash Flow |
| 282.00M | 208.00M | 118.00M | 137.00M | 374.00M | 425.00M | Investing Cash Flow |
| 176.00M | -20.00M | 783.00M | -147.00M | -210.00M | -169.00M | Financing Cash Flow |
| -210.00M | -215.00M | -598.00M | -247.00M | -29.00M | -273.00M |
Tate & Lyle Technical Analysis
Tate & Lyle Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £1.78B | 14.50 | 9.02% | 0.83% | 5.90% | 11.24% | |
78 Outperform | £113.94B | 23.80 | 30.27% | 3.19% | -0.76% | -12.83% | |
77 Outperform | £14.80B | 11.66 | 11.89% | 3.05% | -0.38% | 14.68% | |
76 Outperform | £2.45B | 39.24 | 3.39% | 3.47% | -11.03% | -2.05% | |
70 Outperform | $43.41B | 15.44 | 35.82% | 3.91% | -3.88% | -11.33% | |
65 Neutral | $8.88B | 15.01 | 4.76% | 203.76% | 3.54% | -2.49% | |
63 Neutral | £77.09B | 25.75 | 5.92% | 6.69% | -5.19% | ― |
Tate & Lyle Corporate Events
Tate & Lyle PLC announced a change in the voting rights held by BlackRock, Inc., which now holds 5.45% of the total voting rights in the company. This adjustment in BlackRock’s holdings may impact Tate & Lyle’s shareholder dynamics and influence future corporate decisions, reflecting BlackRock’s strategic interest in the company.
Spark’s Take on GB:TATE Stock
According to Spark, TipRanks’ AI Analyst, GB:TATE is a Outperform.
Tate & Lyle scores well due to its strong financial health, solid valuation, and positive corporate events, reflecting confidence in future prospects. However, declining revenue and mixed technical indicators suggest caution in the near term. The successful integration of CP Kelco and strategic initiatives further enhance its outlook.
To see Spark’s full report on GB:TATE stock, click here.
BlackRock, Inc., a major shareholder in Tate & Lyle PLC, has adjusted its voting rights holdings, now holding 5.45% of the total voting rights. This change in BlackRock’s stake reflects a slight decrease in direct voting rights but maintains the overall percentage, potentially impacting shareholder dynamics and influencing future corporate decisions.
Spark’s Take on GB:TATE Stock
According to Spark, TipRanks’ AI Analyst, GB:TATE is a Outperform.
Tate & Lyle scores well due to its strong financial health, solid valuation, and positive corporate events, reflecting confidence in future prospects. However, declining revenue and mixed technical indicators suggest caution in the near term. The successful integration of CP Kelco and strategic initiatives further enhance its outlook.
To see Spark’s full report on GB:TATE stock, click here.
Tate & Lyle has announced a change in the voting rights held by BlackRock, Inc., a major shareholder. As of April 25, 2025, BlackRock’s total voting rights in Tate & Lyle have increased from 5.26% to 5.45%, indicating a slight increase in their stake. This adjustment in holdings reflects BlackRock’s continued interest and investment in Tate & Lyle, potentially impacting the company’s governance and strategic decisions.
Spark’s Take on GB:TATE Stock
According to Spark, TipRanks’ AI Analyst, GB:TATE is a Outperform.
Tate & Lyle scores well due to its strong financial health, solid valuation, and positive corporate events, reflecting confidence in future prospects. However, declining revenue and mixed technical indicators suggest caution in the near term. The successful integration of CP Kelco and strategic initiatives further enhance its outlook.
To see Spark’s full report on GB:TATE stock, click here.
Tate & Lyle PLC has announced a change in the voting rights held by Black Creek Investment Management Inc., a Canadian investment management company. The notification indicates that Black Creek’s voting rights have decreased slightly from 3.024979% to 2.992493%, involving shares beneficially owned by 12 separate funds and clients. This adjustment in holdings does not affect any single fund or client reaching the 3% threshold, and Black Creek retains the discretion to exercise voting rights for the shares held.
Spark’s Take on GB:TATE Stock
According to Spark, TipRanks’ AI Analyst, GB:TATE is a Outperform.
Tate & Lyle scores well due to its strong financial health, solid valuation, and positive corporate events, reflecting confidence in future prospects. However, declining revenue and mixed technical indicators suggest caution in the near term. The successful integration of CP Kelco and strategic initiatives further enhance its outlook.
To see Spark’s full report on GB:TATE stock, click here.
Tate & Lyle has successfully integrated CP Kelco, operating as a combined business from April 2025, and is on track to deliver targeted synergies. The company expects its financial results for the year ending March 2025 to align with guidance, showing strong cash flow and improved EBITDA margins. This integration is expected to enhance Tate & Lyle’s market position, with a focus on delivering value through a new organizational framework and increased customer engagement.
Spark’s Take on GB:TATE Stock
According to Spark, TipRanks’ AI Analyst, GB:TATE is a Neutral.
Tate & Lyle’s overall stock score reflects its solid financial health and stable balance sheet, balanced by concerns over declining revenue and technical indicators suggesting near-term caution. The company’s strategic initiatives and positive corporate events, such as managerial share purchases and successful M&A integration, contribute positively to its outlook, although technical analysis indicates potential short-term volatility.
To see Spark’s full report on GB:TATE stock, click here.
Tate & Lyle PLC announced the appointment of Steve Foots as a non-executive director and member of the Remuneration and Nominations Committees, effective after the Annual General Meeting in July 2025. Foots, currently the Chief Executive of Croda International Plc, brings strategic and operational expertise that is expected to support Tate & Lyle’s growth agenda. Concurrently, Lars Frederiksen will retire from the Board after nine years of service. These changes are aimed at strengthening the company’s leadership as it continues to focus on innovation and customer satisfaction.
Tate & Lyle PLC announced that Sarah Kuijlaars, the Chief Financial Officer, will resign from her position as a non-executive director at Inchcape PLC due to scheduling conflicts with her executive responsibilities at Tate & Lyle. This decision reflects the company’s focus on its internal operations and commitment to its strategic goals, potentially impacting its governance structure and stakeholder relations.
Tate & Lyle has announced a change in its major holdings, with BlackRock, Inc. adjusting its voting rights in the company. As of March 10, 2025, BlackRock’s total voting rights in Tate & Lyle have decreased slightly from 5.31% to 5.26%. This adjustment in holdings may influence the company’s market positioning and stakeholder dynamics, reflecting BlackRock’s strategic financial decisions.
Tate & Lyle PLC announced a transaction involving the acquisition of 8,200 ordinary shares by David Hearn, a Person Discharging Managerial Responsibilities (PDMR), and Laurie Hearn, a person closely associated (PCA). The shares were purchased at a price of £5.376255 each, totaling £44,085.29. This transaction, conducted on the London Stock Exchange, increases Mr. Hearn and his PCA’s total shareholding to 27,261 shares, reflecting confidence in the company’s prospects and potentially impacting stakeholder perceptions positively.
Black Creek Investment Management Inc., based in Toronto, Canada, has increased its voting rights in Tate & Lyle PLC to 3.024979% as of February 26, 2025. This acquisition signifies a slight increase from its previous holding of 2.999830%, highlighting Black Creek’s growing influence in the company. The shares are held by 12 separate funds and clients advised by Black Creek, which exercises voting rights on their behalf. This development may impact Tate & Lyle’s shareholder dynamics and strategic decisions moving forward.
Tate & Lyle PLC announced a transaction involving Sarah Kuijlaars, the Chief Financial Officer, who acquired 20,000 ordinary shares at £5.645 each, totaling £112,900. This transaction, conducted on the London Stock Exchange, increases Kuijlaars’ total holdings to 40,000 shares, reflecting confidence in the company’s future prospects and potentially influencing stakeholder perceptions of its market stability.
Tate & Lyle PLC has applied for a block listing of 275,000 ordinary shares to be admitted to the Official List of the UK Listing Authority and traded on the London Stock Exchange. This move, related to the company’s Sharesave Plans, is expected to enhance the company’s liquidity and provide additional opportunities for employee investment.
Tate & Lyle PLC announced that Glenn Fish, a non-executive director, has acquired 1,000 American Depositary Receipts (ADRs) in the company, each representing four ordinary shares. This transaction reflects Fish’s growing interest in Tate & Lyle, totaling 3,960.4 ADRs equivalent to 15,841.6 shares. The transaction, conducted on the OTCQX exchange, underscores the company’s compliance with the Market Abuse Regulation and highlights potential confidence in the company’s prospects by its managerial personnel.
Tate & Lyle has reported a solid operating performance for the quarter ending December 2024, marked by volume and EBITDA growth, despite a 4% revenue decline due to input cost deflation. The acquisition and integration of CP Kelco are progressing well, with expected synergies reinforcing the company’s growth-focused strategy. This strategic move enhances Tate & Lyle’s market position, particularly in the mouthfeel segment, and supports their long-term goals of profitable volume growth and strong cash flow amidst geopolitical uncertainties and pricing pressures.